Target intelligence / Profile preview

Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G pseudogene

Molecular classification
Other, Pseudogene
01

Overview

**Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G pseudogene (ENSG00000257281, also known as LOC196469)** is classified as a pseudogene and not a protein-coding gene or functional therapeutic target[1][5]. Pseudogenes are non-functional segments of DNA that resemble functional genes but typically do not encode active proteins or have biological activity. This specific pseudogene shows high sequence similarity to the gene encoding APOBEC3G, an RNA-editing cytidine deaminase enzyme family member involved in innate immunity, but it does not have the known enzymatic or receptor functions of its protein-coding counterpart. There is no evidence of drug interaction, disease association, biomarker utility, or safety/toxicity relevance for this pseudogene. **Note:** This entry represents a non-coding, non-functional pseudogene and is not considered a valid therapeutic target. If the intended target was APOBEC3G (the active gene/protein), please clarify; the current entry does not encode a functioning protein or established biological function[1][5].

Other names
LOC196469ENSG00000257281Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G (APOBEC3G) pseudogene

Beyond the preview

Go deeper on Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call